Evidence for E-cadherin’s role as a tumor suppressor has accumulated, with downregulation of CDH1 being linked with epithelial tumor progression [79, 80], although its reexpression in tumors is reported to promote metastasis in later stages of tumor progression (reviewed in [14]). Here, CDH1 is linked to neoplasm.